Cancer treatment has seen a big change with immune checkpoint blockade (ICB) therapy. This therapy works by waking up the body's immune system to fight cancer. However, it doesn't always work well with solid tumors. The immune response might not be strong enough. To tackle this, scientists have come up with a clever plan. They combined ICB with a special kind of nano...
Prostate cancer is a big deal. It's a major health problem that hits a lot of people. The search for better treatments is always on. One exciting development is a unique drug combination. This mix includes a targeted radioactive material and a specific inhibitor. The radioactive material is called lutetium-177-PSMA. It's not your average radioactive stuff. Thi...
Medical history is crucial for accurate diagnoses. Yet, it's often missing in CT scan orders for the abdomen or abdomen/pelvis. This gap can lead to incomplete radiology reports. So, a study looked into how often malignancy history is documented in these CT scan orders. It also checked if this history makes it into the final radiology reports when it's not in the ini...
Breast cancer is a serious issue. It is one of the most common types of cancer in women. It is known for its ability to spread quickly and aggressively. This is due to a specific type of cell called breast cancer stem cells. These cells are particularly troublesome because they can migrate and invade other parts of the body. This makes it hard to treat and cure. ...
Colorectal cancer is a serious and widespread health issue. It is expected to cause nearly 53, 000 deaths in the US this year. This type of cancer is becoming more common among younger adults, which is a worrying trend that scientists are trying to understand. Early detection and prevention are crucial for improving survival rates and treatment outcomes. The US Preve...
Breast cancer patients often face a tough decision after a mastectomy: should they opt for conventional or hypofractionated radiation therapy? This question has been the subject of recent studies. The focus is on the risks of secondary cancers in the opposite breast and the same-side lung. This is a big deal because radiation, while killing cancer cells, can also ...
Afatinib and capecitabine are two drugs that are being tested together in a clinical trial. This trial is for people who have cancers that are hard to treat. These cancers include pancreatic ductal adenocarcinoma, biliary tract cancers, and other solid tumors. The epidermal growth factor receptor is a protein. It is found on the surface of cells. It helps ce...
Bile duct cancer, also known as biliary tract carcinoma, is a tough nut to crack. It is a serious disease that has not seen many breakthroughs in treatment. It is not all doom and gloom, though. Researchers have been testing out different ways to fight this disease. They have been looking at combining different types of treatments to see if they can improve the o...
Breast cancer is the most frequent type of cancer among women. It has been a growing concern for many years. Early detection is key to improving survival rates and reducing deaths. This is where metabolomics comes into play. It is a field of study that looks at the chemicals produced by the body's metabolic processes. These chemicals can provide valuable insights int...
LGBTQ+ individuals face a unique set of challenges when they become cancer caregivers. These challenges often lead to financial struggles and job changes. A recent study looked into how these changes affect the financial well-being of LGBTQ+ caregivers. The study found that many caregivers had to deal with increased costs, lost wages, and strained finances. This w...